Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study

MDI53
  • Microdosing psilocybin significantly increased feelings of awe in participants when exposed to awe-inspiring videos.
  • Despite augmenting feelings of awe, microdosing did not elicit significant differences in aesthetic experiences related to viewing various artworks.
  • The majority of participants correctly identified whether they were in the psilocybin or placebo groups, suggesting that expectancy effects may significantly influence reported outcomes.

Study Overview

The researchers conducted a double-blind placebo-controlled study with 30 participants to investigate the effects of psilocybin microdosing on feelings of awe and aesthetic experiences. Psilocybin, a psychoactive compound found in certain mushrooms, was administered at a microdose of 1.5mg, with participants receiving 5-7 doses over the course of three weeks. However, a significant number of participants were able to deduce whether they received placebo or psilocybin, raising questions about the validity of the findings due to potential expectancy effects.

Methodology

The study systemized a blend of lab and field approaches, incorporating a microdosing workshop where participants learned to create their doses. Following this, they self-administered psilocybin or a placebo in alternating three-week blocks, maintaining a blind condition for both participants and researchers. Testing occurred twice during each block, allowing the study to measure the effects of microdosing on feelings of awe and aesthetic appreciation.

The participants rated their feelings of awe while viewing awe-inducing videos and abstract artworks, and completed the Tellegen Absorption Scale to gauge their ability to immerse in sensory experiences. The researchers also assessed participants’ expectations concerning the effects of microdosing.

Results Analysis

Key findings revealed that psilocybin use resulted in heightened feelings of awe, particularly when participants viewed awe-inspiring videos compared with when they were given a placebo. However, no significant differences in aesthetic experiences emerged when participants viewed a range of artworks. Notably, a substantial proportion of participants recognized their group allocation, which may have influenced their experiences.

In exploratory analyses, stronger participant expectations about microdosing’s positive effects correlated with heightened feelings of awe. When treating expectations as a covariate, the direct effect of psilocybin on awe diminished, reinforcing the idea that beliefs about the substance’s efficacy potentially shaped the outcomes observed.

Discussion and Implications

The researchers emphasized the importance of their findings while recognizing key limitations, such as the breaking of blind conditions and participants’ strong pre-existing beliefs about microdosing benefits. They proposed that these factors might have prompted motivated reasoning or social desirability in their responses. Additionally, the intensity of awe experienced was inherently more pronounced in initial sessions, suggesting a possible habituation to psilocybin’s effects over time.

Finally, they concluded that further systematic and controlled research is necessary to clarify the effects of psilocybin microdosing while also acknowledging the unique setting in which this study was conducted. The study raises intriguing questions for future research on the psychological impacts of microdosing, particularly in relation to the expectations participants bring to the experience.

Read the full paper summary on Blossom.

Science

Is Microdosing Just a Placebo? What Placebo-Controlled Studies Show

Placebo-controlled studies show that microdoses measurably change the brain and body, but so far they find few consistent improvements in mood or wellbeing beyond placebo. Surveys and personal reports are far more positive, and part of that gap is explained by expectation and by participants guessing what they took. Below

JOIN OUR COMMUNITY!

 Want to stay updated about microdosing research, the latest news, tips & tricks, and more? Subscribe to our newsletter below and stay in the loop about everything microdosing!